CollPlant Biotechnologies (CLGN) Amortization of Deferred Charges (2020 - 2024)
CollPlant Biotechnologies (CLGN) posted Amortization of Deferred Charges of $173000.0 for Q3 2024, up 30.08% on a QoQ basis from $133000.0 in Q3 2023, and up 30.08% year-over-year from $133000.0 in Q4 2023.
CollPlant Biotechnologies (CLGN) Amortization of Deferred Charges (2020 - 2024) Analysis & Trends
CollPlant Biotechnologies' Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $173000.0 for Q3 2024.
- Quarterly Amortization of Deferred Charges rose 30.08% year-over-year to $173000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $560000.0 (down 33.96% YoY) and the FY2022 annual result came in at $461000.0, up 15.25% from the prior year.
- Amortization of Deferred Charges was $173000.0 for Q3 2024 at CollPlant Biotechnologies, up from $133000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $461000.0 in Q4 2022 and bottomed at $50000.0 in Q1 2020.
- A 5-year average of $139692.3 and a median of $112000.0 in 2021 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges jumped 311.61% — and 2023, when it rose 6.4%.
- CollPlant Biotechnologies' Amortization of Deferred Charges stood at $50000.0 in 2020, then surged by 124.0% to $112000.0 in 2021, then soared by 311.61% to $461000.0 in 2022, then sank by 71.15% to $133000.0 in 2023, then jumped by 30.08% to $173000.0 in 2024.
- Business Quant data shows CLGN's Amortization of Deferred Charges at $173000.0 in Q3 2024, $133000.0 in Q3 2023, and $135000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Jun 30, 2023 | 135,000.00 |
| Jun 30, 2023 | 135,000.00 |
| Mar 31, 2023 | 119,000.00 |
| Mar 31, 2023 | 119,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Sep 30, 2022 | 125,000.00 |
| Sep 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |